Clinical Trials Directory

Trials / Conditions / Influenza B

Influenza B

24 registered clinical trials studyying Influenza B — 5 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingClinical Validation of an At-Home Flu A/B and COVID-19 Rapid Test
NCT07430410
CorDx, Inc.N/A
Not Yet RecruitingAdaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp)
NCT07314905
Unity Health TorontoPhase 3
Not Yet RecruitingClinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Se
NCT07217639
Aptitude Medical SystemsN/A
Not Yet RecruitingPhase III Clinical Trial of Quadrivalent Influenza Virus Split Vaccine
NCT06800950
Institute of Medical Biology, Chinese Academy of Medical SciencesPhase 3
CompletedProspective Clinical Evaluation of COVID/Flu Detect™ Rapid Self-Test in Symptomatic Subjects for Non-Prescript
NCT06734741
InBios International, Inc.—
CompletedCovid Flu A/B and RSV 4 in 1 Diagnostic Test
NCT07308158
iHealth Labs inc—
CompletedEvaluation of COVID-19 and Flu A/B 3 in 1 Combo Rapid Test
NCT07190131
iHealth Labs inc—
RecruitingA Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients
NCT06672692
DiaSorin Molecular LLCN/A
CompletedPredict + Protect Study: Exploring the Effectiveness of a Predictive Health Education Intervention on the Adop
NCT06229444
Evidation HealthN/A
CompletedWearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Be
NCT06207929
Evidation Health—
UnknownClinical Performance Study for EDAN's COVID-19/Flu A/Flu B/RSV Test Kits on Subjects Suspected of Respiratory
NCT06175611
EDAN Instruments Inc.—
CompletedSARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings
NCT06191393
Aptitude Medical SystemsN/A
CompletedClinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel
NCT06127108
Abbott Rapid DxN/A
UnknownDose, Safety, and Pathogenicity of a New Influenza B Strain
NCT06254820
HvivoPhase 2
UnknownClinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Re
NCT05787444
LumiraDx UK Limited—
CompletedMGC Health COVID-19 & Flu A+B Home Multi Test Usability Study
NCT05732610
Medical Group Care, LLCN/A
CompletedPerformance Evaluation of the LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B Tests at Point of
NCT05728970
LumiraDx UK Limited—
TerminatedVitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml
NCT04810949
Hospital Clinica NovaN/A
CompletedValidation of the Ellume® Respirio Flu Test and the Ellume® eLab Flu Test for the Rapid Identification of Infl
NCT02767414
Ellume Pty LtdN/A
CompletedValidation of the Respirio Flu Test for the Rapid Identification of Influenza A/B
NCT02487173
Ellume Pty LtdN/A
CompletedEvaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults H
NCT02287467
National Institute of Allergy and Infectious Diseases (NIAID)Phase 3
CompletedDetection of Influenza A, Influenza B, and RSV Using the Liat™ Assays on the Liat™ Analyzer
NCT02067286
IQuum, Inc.—
CompletedCollection and Testing of Respiratory Samples
NCT01302418
QIAGEN Gaithersburg, Inc—
CompletedSafety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
NCT01052480
National Institute of Allergy and Infectious Diseases (NIAID)Phase 2